Study: Commercially available antibodies used to investigate modification of key cancer braking mechanism aren’t fully reliable

When researchers study rare diseases, breakthroughs can be made that help patients. Revisit studies that are putting genetic puzzle pieces together to tackle these conditions.

Proof-of-concept research points to wearable monitors’ potential to offer low-cost, non-invasive way to detect this dangerous bone-marrow transplant complication.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

Members of the U-M Rogel Cancer Center continue to push the boundaries of cancer prevention, diagnosis and treatment.

An interdepartmental team at the University of Michigan obtains a prestigious NIH grant that will support an advanced imaging strategy to improve methods for early cancer detection.